Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2659 stock hub

HKG/2659 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2659is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.9B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2659

In the news

Latest news · HKG/2659

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-30.6

P25 -14.7P50 2P75 9.4

ROIC-12.4

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2659 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

143

Groups with data

Currency

CNY

Showing 143 of 143 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	354
Enterprise value	HKD 7.9B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	HKD 8.9B
Price	HKD 27.4
Price currency	HKD
Rev Per Employee	154,523.45x
Sector	Healthcare
Sic	2836
Symbol	hkg/2659
Website	https://www.baopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.93%
EV Earnings	-17.96x
EV/FCF	-21.29x
EV/Sales	144.41x
FCF yield	-4.15%
P/B ratio	5.04x
P/S ratio	163.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	89%
Gross Profit	HKD 48.7M
Gross Profit Growth	-4.28%
Gross Profit Growth Q	-49.1%
Net Income	HKD -439.9M
Pretax Margin	-804.18%
Profit Per Employee	HKD -1.2M
ROA	-10.79
ROCE	-16.38
ROE	-30.55
ROIC	-12.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	697.99x
Revenue Growth Q	53.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.03
Assets	HKD 2.5B
Cash	HKD 1.4B
Current Assets	HKD 1.6B
Current Liabilities	HKD 380.8M
Debt	HKD 350.5M
Debt Equity	HKD 0.2
Debt FCF	HKD -0.94
Equity	HKD 1.8B
Interest Coverage	-51.73
Liabilities	HKD 695.5M
Long Term Assets	HKD 897.3M
Long Term Liabilities	HKD 314.7M
Net Cash	HKD 1B
Net Cash By Market Cap	HKD 11.56
Net Cash Growth	189.92%
Net Debt Equity	HKD -0.58
Tangible Book Value	HKD 1.8B
Tangible Book Value Per Share	HKD 5.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.12
Inventory Turnover	0.99
Net Working Capital	HKD -105.6M
Quick ratio	3.76
Working Capital	HKD 1.1B
Working Capital Turnover	HKD 0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	97.99
All Time High	206
All Time High Change	-86.7%
All Time High Date	2026-02-25
All Time Low	23.34
All Time Low Change	17.4%
All Time Low Date	2026-05-06
ATR	10.32
Beta1y	3.76
Ch YTD	-64.67
High	29.32
High52	206
High52 Date	2026-02-25
High52ch	-86.7%
Low	24.58
Low52	23.34
Low52 Date	2026-05-06
Low52ch	17.4%
Ma50ch	-72.04%
RSI	20.87
RSI Monthly	0
RSI Weekly	39.13
Sharpe ratio	-0.32x
Sortino ratio	-0.34
Total Return	-8.43%
Tr YTD	-64.67
Tr1m	-73.35%
Tr1w	5.3%
Tr3m	-75.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -343.9M
Operating margin	-628.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	72,924,820%
Net Borrowing	125,125,386.5
Shares Insiders	36.6%
Shares Institutions	15.52%
Shares Out	325,981,465
Shares Qo Q	1.52%
Shares Yo Y	8.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD -478.8M
Average Volume	3,967,775x
Bv Per Share	5.43
CAPEX	HKD -170.7M
Ch1m	-73.35
Ch1w	5.3
Ch3m	-75.32
Change	9.16%
Change From Open	7.96
Close	25.1
Days Gap	1.12
Depreciation Amortization	39,613,769
Dollar Volume	607,746,248
Earnings Date	2026-03-26
EBIT	HKD -343.9M
EBITDA	HKD -305.6M
EPS	HKD -1.52
F Score	2
FCF	HKD -371M
FCF EV Yield	-4.7x
FCF Per Share	HKD -1.14
Financing CF	1,110,618,012
Fiscal Year End	December
Founded	2,019
Investing CF	-103,444,615
Is Primary Listing	1
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Ma20	68.56
Ma20ch	-60.04%
Net CF	798,386,825
Open	25.38
Position In Range	59.49
Ppne	845,543,231.4
Price Date	2026-05-08
Ptbv Ratio	5.08
Relative Volume	5.59x
Revenue	54,701,301x
SBC By Revenue	197.1x
Share Based Comp	107,815,734
Volume	22,180,520
Z Score	19.9

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2659 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns HKG/2659?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.5%

Share of float held by funds and institutions

Insider ownership

+36.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+8.4%

Negative means the company is buying back shares.

Technical

HKG/2659 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

20.9

Below 30: short-term oversold

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2659

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2659 stock rating?

hkg/2659 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2659 analysis?

The full report lives at /stocks/hkg/2659/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2659?

The latest report frames hkg/2659 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2659 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.